Cart summary

You have no items in your shopping cart.

LY344864

SKU: orb1223215

Description

LY344864 is a selective 5-HT1F receptor agonist with an affinity of 6 nM (Ki) at the recently cloned 5-HT1F receptor. LY344864 possesses little affinity for the 56 other serotonergic and non-serotonergic neuronal binding sites examined. LY344864 was shown to be a full agonist producing an effect similar in magnitude to serotonin itself.

Images & Validation

Key Properties

CAS Number186544-26-3
MW351.42
Purity>98% (HPLC)
FormulaC21H22FN3O
SMILESCN(C)[C@@H]1CCc2c(C1)c1c([nH]2)ccc(c1)NC(=O)c1ccc(cc1)F.Cl
TargetFGFR
SolubilityDMSO : ≥ 350 mg/mL; 995.96 mM

Bioactivity

In Vivo
LY 344864 (0-10 ng/kg; p.o. or i. v. ; once) inhibits neurogenic dural inflammation in rat migraine pain model. LY 344864 (1 mg/kg; i. v. ; once) can cross the blood brain barrier to some extent in rats. LY 344864 (2 mg/kg; i.p.; daily for 14 days) attenuates dopaminergic neuron loss and improved behavioral endpoints in a Parkinson’s disease mouse model. Animal model: Male Wistar rats, migraine pain model. Dosage: 1-10 ng/kg (oral), 0.3-2 ng/kg (intravenous). Administration: Oral, 75 minutes before trigeminal stimulation or intravenous, 10 minutes before trigeminal stimulation. Result: When given intravenously 10 minutes before stimulation, inhibited inflammation with an ID50 (median infective dose) of 0.6 ng/kg. When administered orally 75 minutes before trigeminal stimulation, an ID50 of 1.2 ng/kg was obtained. Animal model: Male C57BL/6 mice, Parkinson’s disease model. Dosage: 2 mg/kg. Administration: Intraperitoneal injection, daily for 14d beginning 7d post-lesion. Result: Attenuated TH-ir loss in the striatum and substantia nigra compared to vehicle-treated lesioned animals, also increased locomotor activity in 6-hydroxydopamine lesioned mice, while vehicle treatment had no effect.
In Vitro
LY 344864 binds to human 5-HT1F, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT3A, 5-HT2B, 5-HT2C, 5-HT7, rat α1-adrenergic, rat α2-adrenergic receptors with Kis of 0.006, 0.530, 0.549, 0.575, 1.415, 3.935, 1.695, 3.499, 4.851, 5.06 and 3.69 μM, respectively. LY 344864 is a inducer of mitochondrial biogenesis.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

LY-344864 | LY344864 | LY-344864 HCl

Similar Products

  • LY 344864 [orb1703992]

    98.00%

    186544-26-3

    351.42

    C21H22FN3O

    25 mg, 1 ml x 10 mM (in DMSO), 2 mg, 5 mg, 10 mg, 50 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

LY344864 (orb1223215)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 80.00
5 mg
$ 100.00
10 mg
$ 150.00
25 mg
$ 250.00
50 mg
$ 430.00
100 mg
$ 740.00